Jim Simons started to build up the position in Protagenic Therapeutics in Q3 2021 and continued to invest until Q1 2022. Since then they sold 25.5 Thousand shares. The investor completely sold their stake between Q2 2022 and Q4 2022.
Avg closing price
Price range
Sold -5.26 Thousand shares
Q4 2022
Avg closing price
$2.15
Price range
$1.40
-
$2.60
Sold 58.1% shares (-7.29 Thousand shares)
Q3 2022
Avg closing price
$2.64
Price range
$2.28
-
$3.19
Sold 50.9% shares (-13 Thousand shares)
Q2 2022
Avg closing price
$3.17
Price range
$2.59
-
$3.66
Increased shares by 69.2% (+10.5 Thousand shares)
Q1 2022
Avg closing price
$4.25
Price range
$3.21
-
$5.80
Increased shares by 160.3% (+9.3 Thousand shares)
Q4 2021